Diazyme Laboratories is a Division of General Atomics headquartered in La Jolla, California. Diazyme Laboratories uses its platform enzyme technologies including enzyme cycling, Substrate-Trapping-Enzyme (STE), and Allosteric Enzyme Coupled ImminoAssay (AECIA), to develop low cost and robust diagnostic products for clinical laboratories. Diazyme’s focus is to develop enzyme based diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme’s products include diagnostic blood tests for liver disease, cardiac markers, diabetes and electrolytes. Diazyme is a cGMP and ISO13485 certified medical device manufacturer. We manufacture all products in clean room environments following cGMP and ISO guidance. All products are subjected to a thorough QC inspection and testing system before sale. Diazyme guarantees that all of its products meet product specifications and strives for a quality of service that meets the customer’s satisfaction.